Seagen Inc.
DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY
Last updated:
Abstract:
This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
Status:
Application
Type:
Utility
Filling date:
2 May 2022
Issue date:
25 Aug 2022